radiopharmaceuticals
The firm presented early data for a blood-based approach to screen prostate cancer patients for PSMA, which it believes has advantages over PET imaging.
Pentixapharm Begins Phase I/II Trial of Radiopharmaceutical Agent in Leukemia
The trial will include patients with CXCR4-positive acute myeloid leukemia and acute lymphoblastic leukemia.
Novartis Scoops up Ratio Therapeutics' SSTR2-Directed Radiopharmaceutical Capabilities for $745M
Novartis is licensing Ratio's technology and its discovery and development expertise to develop a next-generation radiopharmaceutical.
Telix Pharmaceuticals to License FAP-Targeting Radiopharmaceuticals From German Researchers
The firm is paying €7 million to add fibroblast activation protein-targeting assets to its pipeline, which it will initially develop for bladder cancer.
CMS Rolling Out New Payment Policy for High-Cost Diagnostic Radiopharmaceuticals
The government payor said it will separately pay for specialized diagnostic radiopharmaceuticals without transitional pass-through payment status.
Oct 25, 2024
Alpha-9 Oncology Raises $175M in Series C Financing
Oct 2, 2024
Jul 18, 2024
Jun 6, 2024